Ventana and BD Biosciences to Co-Market DNA Microarrays and Analysis System | GenomeWeb

NEW YORK, July 11 – Ventana Medical Systems and BD Biosciences Clontech Laboratories have agreed to non-exclusively co-market their microarray products, the companies said Wednesday.

Together, the two companies will co-promote BD Biosciences’ DNA microarrays, and Ventana’s microarray analysis platform. Financial details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.